ストックスクリーナーアプリを入手
0.3298
1.70%
-0.0057
Scilex Holding Company (SCLX) 最新ニュース
Scilex (NASDAQ:SCLX) Stock Price Down 1.7% – Time to Sell? - Defense World
Scilex seeks FDA nod for ELYXYB in acute pain management - MSN
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination - The Manila Times
Merger Deadline Extended: Denali Capital's Strategic Move Backed by Interest-Free $180K Funding - StockTitan
The growth track for Scilex Holding Company (SCLX) has changed recently - SETE News
Analytical Lens: Exploring Scilex Holding Company (SCLX)’s Financial Story Through Ratios - The Dwinnex
D. Boral Capital analysts initates a Buy rating for Scilex Holding Company (SCLX) - Knox Daily
Scilex Holding Company [NASDAQ: SCLX] Sees Decrease in Stock Value - Knox Daily
A company insider recently sold 23,343 shares of Newell Brands Inc [NWL]. Should You Sale? - Knox Daily
Sciatica Treatment Market to Reach at a CAGR 9.7% During - openPR
A company insider recently sold 187,500 shares of Solid Power Inc [SLDP]. Should You Sale? - Knox Daily
SCLX’s Stock Market Adventure: -6.00% YTD Growth Amidst Volatility - The InvestChronicle
Investing in Scilex Holding Company (SCLX) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - US Post News
Scilex Dividend Stock lock-up extended to April 14 - MSN
Scilex (NASDAQ:SCLXW) Stock Price Down 4.8% – What’s Next? - Defense World
Investor’s Delight: Scilex Holding Company (SCLX) Closes Weak at 0.41, Down -6.39 - The Dwinnex
UBS Upgrades Rocket Companies Inc (RKT) to a Neutral from a Sell - Knox Daily
Scilex Holding Company (SCLX) rating initates by D. Boral Capital - Knox Daily
Scilex Dividend Stock lock-up extended to April 14 By Investing.com - Investing.com Australia
Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025 - The Manila Times
Scilex Holding Company Announces that the U.S. Bankruptcy - GlobeNewswire
Court Mandates 15-Month Extension on Scilex Dividend Stock Trading Restrictions - StockTitan
SCLX stock touches 52-week low at $0.38 amid market challenges - Investing.com
Scilex (NASDAQ:SCLX) Coverage Initiated by Analysts at D. Boral Capital - Defense World
D. Boral Capital Initiates Coverage of Scilex Holding (SCLX) with Buy Recommendation - MSN
This Vital Farms Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Holding Company Shares Rally Following Board Of Directors Commentary - MSN
Scilex Holding Faces Financial Strain Amid Form S-3 Ineligibility Crisis - TipRanks
SCLX Beats on Earnings as Product Line Expands - MSN
Scilex FDA submission for ELYXYB acute pain treatment acknowledged - MSN
Scilex Holding Company Announces that the U.S. FDA Has Acknowledged the Submission of Our Supplemental New Drug Application for ELYXYB® in Acute Pain Indication - The Manila Times
Scilex Amends Note Maturity and Cash Sweep Terms - TipRanks
Nio Inc ADR (NIO-N) QuotePress Release - The Globe and Mail
Scilex Holding Company Announces that It Regains Nasdaq Compliance Under Listing Rule 5250(c)(1) - The Manila Times
Toyota Motor Corp Ltd Ord ADR (TM-N) QuotePress Release - The Globe and Mail
Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025 - The Manila Times
Scilex Holding Company Announces that Its Note Holders Intend to Participate in the Funding and Licensing of Gloperba® Ex-U.S. Commercialization Rights from Romeg Therapeutics, LLC - The Manila Times
Scilex Holding Company Announces that It Will Be Filing Today of a Supplemental New Drug Application with the FDA for ELYXYB® in Acute Pain Indication - The Manila Times
Scilex Holding Company Announces Filing of its Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2024 - The Manila Times
Nvidia Corp (NVDA-Q) QuotePress Release - The Globe and Mail
Microstrategy Cl A (MSTR-Q) QuotePress Release - The Globe and Mail
Scilex Holding Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Scilex Holding Company (SCLX) reports earnings - Quartz
Jane Street Group LLC Trims Position in Scilex Holding (NASDAQ:SCLX) - Defense World
Scilex Holding Company Amends its License Agreement with Romeg Therapeutics, LLC, For the Worldwide Rights to Commercialize Gloperba®, an FDA-Approved Prophylactic Treatment for Painful Gout Flares in Adults - Yahoo Finance
Scilex Holding Company Expands Global Potential for Gloperba® with License Agreement Amendment for Ex-US Commercialization - Nasdaq
Scilex Holding Company Announces Pain Medicine News Published Retrospective Claims Data on ZTlido® vs. Lidocaine 5% Patch - The Manila Times
Scilex Holding Company Announces Pain Medicine News - GlobeNewswire
Scilex (NASDAQ:SCLXW) Trading Up 22.5% – Here’s Why - Defense World
0.61%
0.07%
大文字化:
|
ボリューム (24 時間):